LCBVX
Price
$41.76
Change
-$0.05 (-0.12%)
Updated
Sep 8 closing price
Net Assets
2.37B
VIVIX
Price
$71.06
Change
-$0.13 (-0.18%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

LCBVX vs VIVIX

Header iconLCBVX vs VIVIX Comparison
Open Charts LCBVX vs VIVIXBanner chart's image
ClearBridge Large Cap Value R
Price$41.76
Change-$0.05 (-0.12%)
VolumeN/A
Net Assets2.37B
Vanguard Value Index I
Price$71.06
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets202.84B
LCBVX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LCBVX vs. VIVIX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCBVX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. LCBVX (2.37B). VIVIX pays higher dividends than LCBVX: VIVIX (2.11) vs LCBVX (0.65). LCBVX was incepted earlier than VIVIX: LCBVX (12 years) vs VIVIX (27 years). LCBVX (1.23) is less costly to investors than VIVIX (0.04). LCBVX is a more actively managed with annual turnover of: 22.00 vs. VIVIX (9.00). LCBVX has a lower initial minimum investment than VIVIX: LCBVX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 8.92 vs. LCBVX (-2.13). VIVIX return over 5 years is better than : 70.91 vs. LCBVX (35.03).
LCBVXVIVIXLCBVX / VIVIX
Total Expense Ratio1.230.043,075%
Annual Report Gross Expense Ratio1.230.043,075%
Fund Existence12 years27 years-
Gain YTD6.1477.66980%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.37B203B1%
Annual Yield % from dividends0.652.1131%
Returns for 1 year-2.138.92-24%
Returns for 3 years21.7531.7768%
Returns for 5 years35.0370.9149%
Returns for 10 years62.19132.7747%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCRTX60.650.41
+0.68%
Morgan Stanley Insight R6
PMVEX26.710.07
+0.26%
PGIM Quant Solutions Mid-Cap Val R2
GWILX16.830.04
+0.24%
Glenmede SMID Core Equity Advisor
SVBIX31.220.05
+0.16%
JHancock Balanced I
GCVRX24.82-0.04
-0.16%
Goldman Sachs Large Cp Val Insghts R